Last chance to register!

Novel Immunotherapeutics Summit
January 29-30, 2015 | Paradise Point Resort & Spa | San Diego, CA
Speakers | Agenda | Venue | Register | Get a Preview

Dear Colleague,

We wanted to let you know the Novel Immunotherapeutics Summit, is happening very soon. Sign up today and attend all three conferences that make up the Summit.  Don't miss this opportunity to hear the latest discoveries and network with top experts from Regeneron, Janssen, Genentech, Pfizer, Amgen, Merck, NCI, NIH, and more!

Click here for a preview of the conference proceedings:

REGISTRATION INFORMATION

Novel Immunotherapeutics Summit Registration
Register for a Summit Passand get access to all three conferences.

Or choose the Single Conference option by clicking the conference below:
          13th Cytokines & Inflammation
          7th Immunotherapeutics & Immunomonitoring
          3rd Immunogenicity & Immunotoxicity

Want to bring your team?
Use the discount codercdvbto sign up three people for the price of two.

PLENARY KEYNOTE SPEAKERS

Shane Crotty, Professor, Vaccine Discovery,La Jolla Institute for Allergy & Immunology-PLENARY KEYNOTE

Francisco Leon, Vice President Translational Medicine, Immunology Development,Janssen R&D-PLENARY KEYNOTE

George Yancopoulos, Chief Scientific Officer,Regeneron-PLENARY KEYNOTE

DISTINGUISHED SPEAKERS - 13th Cytokines & Inflammation

Daniel Appledorn, R&D Project Manager ? Application Support,Essen BioScience

Andre Ballesteros-Tato, Assistant Professor, Medicine,University of Alabama, Birmingham

Joseph Barco, Senior Product Manager, Life Sciences,Singulex

Jay Berzofsky, Chief, Vaccine Branch,National Cancer Institute, NIH

Menno van Lookeren Campagne, Senior Scientist,Genentech

Rachel Caspi, Chief, Immunoregulation Section, Laboratory of Immunology,National Eye Institute, NIH

Hongbo Chi, Member, Immunology,St. Jude Children's Research Hospital

Fabio Cominelli, Professor, Medicine & Pathology,Case Western Reserve University

Scott Durum, Section Chief,National Cancer Institute, NIH

Mark Fritzler, Operations Manager,Eve Technologies Corporation

Grant Gallagher, Managing Direct, and Head of Genetic Immunology,HUMIGEN, the Institute for Genetic Immunology

Nico Ghilardi, Associate Director, Immunology,Genentech

Douglas Green, Chair, Immunology,St. Jude Children's Research Hospital

Thomas Hamilton, Chair, Immunology, Lerner Research Institute,Cleveland Clinic

Brian Idoni, Business Development Manager,Sanguine BioSciences

Jeff Irelan, Global Support Manager,ACEA Biosciences

Lionel Ivashkiv, Associate Chief Scientific Officer and Professor, Research Division and Immunology Program,Hospital for Special Surgery and Weill Cornell Medical College

Dennis Klinman, Senior Investigator, Laboratory of Experimental Immunology,National Cancer Institute, NIH

Ilona Kryczek, Research Assistant Professor,University of Michigan Health Systems

Michael Lotze, Professor, Surgery, Immunology, and Bioengineering,University of Pittsburgh School of Medicine

Joost Oppenheim, Chief, Laboratory of Molecular Immunoregulation,National Cancer Institute, NIH

Kevin Peters, CSO and SVP R&D,Aerpio Therapeutics

Theresa Torres Pizarro, Associate Professor, Pathology,Case Western Reserve University

Dania Rabah, Principal Scientist, Biogen Idec

Kimberly Schluns, Associate Professor,University of Texas MD Anderson Cancer Center

Jennifer Towne,Janssen

Domagoj Vucic, Senior Scientist, Early Discovery Biochemistry,Genentech

Jia Zeng, Director, Scientific Product Development,PharmaLegacy Laboratories (Shanghai)

DISTINGUISHED SPEAKERS - 7th Immunotherapeutics & Immunomonitoring

Dirk Brockstedt, Senior Vice President, Research & Development,Aduro Biotech

Pirouz Daftarian, Assistant Professor, Biochemistry and Molecular Biology,University of Miami Miller School of Medicine

Mark DeBenedette, Director of Immunology,Argos Therapeutics

Joseph Dukes, Head of Preclinical Biology,Immunocore

Bruce Freimark, Research Director, Preclinical o­ncology,Peregrine Pharmaceuticals

Debraj GuhaThakurta, Director, Computational & Systems Biology,Dendreon Corporation

Omid Hamid, Director, Clinical Research and Immunotherapy,Los Angeles Clinic and Research Institute

Michael Hanna Jr., Chairman & Chief Executive Officer,Vaccinogen

Ulrich Hoffmueller, Chief Business Officer and Founder,Epiontis

Frank Jones, Chairman and Chief Executive Officer,Etubics Corporation

Mary Keir, Scientist, Immunology Diagnostic Discovery,Genentech

Samir Khleif, Director, GRU Cancer Center; Professor of Medicine,Medical College of Georgia

Li-Fen Lee, Senior Principal Scientist,Pfizer

Peter Lee, Billy Wilder Endowed Professor; Chair, Dept. of Cancer Immunotherapeutics & Tumor Immunology (CITI),City of Hope Comprehensive Cancer Center

Ravi Madan, Clinical Director, Genitourinary Malignancies Branch,National Cancer Institute, NIH

Stefanie Mandl, Director, Preclinical Research,Bavarian Nordic

Yoav Peretz, Scientific Director, Immunology,ImmuneCarta Services

Paul Polakis, Staff Scientist, o­ncology Research,Genentech

Laszlo Radvanyi, Chief Scientific Officer,Lion Biotechnologies

Margo Roberts, Chief Scientific Officer,Kite Pharma

Peter Schafer, Senior Principal Investigator, Translational Development,Celgene

Judith Varner, Professor of Medicine,University of California, San Diego

Steffen Walter, Vice President Immunology,Immatics Biotechnologies

Xiuli Wang, Associate Research Professor, Hematology and hematopoietic Cell Transplantation,City of Hope National Medical Center

Jon Wigginton, Senior Vice-President, Clinical Development,MacroGenics

Cassian Yee, Professor, Melanoma Medical o­ncology and Immunology; Director, Solid Tumor Cell Therapy,MD Anderson Cancer Center

DISTINGUISHED SPEAKERS - 3rd Immunogenicity & Immunotoxicity

Bjoern Peters, Associate Professor, Center for Infectious Disease,La Jolla Institute for Allergy & Immunology-KEYNOTE

Michael Anderson, Chief Scientific Officer,BDS Immunoassay Services

Etiena Basner-Tschakarjan, Research Associate, Pediatrics,The Children's Hospital of Philadelphia

Gary Bembridge, Director of Scientific Affairs, Immunology,Antitope, an Abzena Company

Lawrence Berliner, Professor, Chemistry and Biochemistry,University of Denver; Emeritus,Ohio State University

Joerg Bluemel, Development o­ncology Portfolio Leader,Genentech

Xiao-Yan Cai, Director, Biologics Bioanalytical Development,Merck

Edward A. Clark, Professor, Immunology,University of Washington

Asa Marknell DeWitt, Senior Scientist, ImmunoDiagnostics,Thermo Fisher Scientific

Martin Gleeso, Chief Scientific Officer,Genalyte

Dominique Gouty, Vice President,BioAgilytix

M. Benjamin Hock, Sr. Scientist, Clinical Immunology,Amgen

Jane Homan, Chief Executive Officer,EigenBio

Bette Korber, Laboratory Fellow,Los Alamos National Laboratory

Arno Kromminga, Chief Executive Officer,IPM Biotech

Harald Kropshofer, Senior Personalized Healthcare Leader, Pharmaceutical Development,F. Hoffmann-La Roche

Christian Schoneich, Takeru Higuchi Distinguished Professor and Chair, Pharmaceutical Chemistry,The University of Kansas

Nikolai Schwabe, Chief Executive Officer,ProImmune Limited

Li Xue, Senior Principal Scientist, PDM-Immunogenicity Sciences,Pfizer

SPONSORSHIP & EXHIBITOR OPPORTUNITIES

GTC offers comprehensive sponsorship packages for all our meetings, including presentation opportunities, exhibit and booth space, as well as the event delegate list. All our packages can be customized to meet your company's budget. For more information, please contact
Steve Holmstromat 626-256-6405 x111 orspex@gtcbio.com

UPCOMING CONFERENCES

Novel Immunotherapeutics Summit| January 29-30, 2015 | San Diego, CA
              13th Cytokines & Inflammation
              7th Immunotherapeutics & Immunomonitoring
              3rd Immunogenicity & Immunotoxicity
 
Catalyses in Drug Discovery Summit| February 26-27, 2015 | San Diego, CA
10% discount by January 26, 2015
             5th Ubiquitin Research & Drug Discovery
              Protease Inhibitors in Drug Discovery
              Enzymes in Drug Discovery

Biomarker Summit| March 18-20, 2015 | San Diego, CA
20% discount by January 18, 2015
              8th o­ncology Biomarkers
              4th Neurological Biomarkers
              4th Inflammatory & Immunological Biomarkers

7th Ocular Diseases Drug Discovery| March 19-20, 2015 | San Diego, CA
20% discount by January 19, 2015

Diabetes Summit| April 27-29, 2015 | Boston, MA
20% discount by February 27, 2015
              8th Diabetes Drug Discovery & Development
              5th Diabetes Partnering & Deal-Making

Stem Cell Summit| April 27-29, 2015 | Boston, MA
20% discount by February 27, 2015
              12th Stem Cell Research & Regenerative Medicine
              4th Stem Cell Product Development & Commercialization

European Pharma Summit| May 5-8, 2015 | Berlin, Germany
20% discount by March 5, 2015         (May 5-6, 2015)
              9th Drug Design & Medicinal Chemistry
              2nd Bioanalytical Sensors 
20% discount by March 5, 2015                        (May 5-7, 2015)
              2nd Tissue Models & Phenotypic Screening          
20% discount by March 7, 2015                        (May 7-8, 2015)
              10th Protein Kinases in Drug Discovery
              2nd GPCR Targeted Screening                      

The Pan-Omics Summit| May 21-22, 2015 | Boston, MA
20% discount by March  21, 2015
              5th Next Generation Sequencing
              2nd Metabolomics: Advances & Applications in Human Disease
              Epigenomics & Novel Therapeutic Targets
              Functional Genomics & Predictive Medicine

Molecular Diagnostics Summit| June 11-12, 2015 | San Diego, CA
20% discount by April 11, 2015
              Cancer Markers & Liquid Biopsies
              Companion Diagnostics
              Pathology Diagnostics
              Point-of-Care Diagnostics

Infectious Disease World Summit| July 8-10, 2015 | Boston, MA
20% discount by May 8, 2015
              13th Vaccines Research & Development: All Things Considered
              12th Anti-Infectives Partnering & Deal-Making
              4th Influenza Research & Development

Other news »

---

• The collaborative mission of IMPE-QN, WHO, and RAI investigates malaria situation in Khanh Hoa province (11/28/2023)
• IMPE-QN cooperated with Korea's leading universities in Bio-health research and training (11/20/2023)
• IMPE-QN welcomes international units to visit and exchange research cooperation (06/05/2023)
• MOU Signing Ceremony and Joint Scientific Seminar between the Institute of Malariology, Parasitology and Entomology and Gyeongsang National University (Republic of Korea) (12/09/2022)
• US Naval Medical Research Unit (NAMRU-2) visits to and exchanges research cooperation with IMPE-QN (08/16/2022)